REFRACTIVE LASER SURGERY STUDIES' INCLUSION CRITERIA SHOULD BE TIGHTENED, PANEL SAYS; NEGATIVE EFFECT ON PATIENT ENROLLMENT RAISED AS CONCERN BY INDUSTRY REP
This article was originally published in The Gray Sheet
Executive Summary
Inclusion criteria for patients in clinical trials of refractive eye surgery lasers should be tightened, FDA's Ophthalmic Devices Panel concluded at its Oct. 21 meeting in Gaithersburg, Maryland.